FDA approves brain implant to help reduce Parkinson’s disease and essential tremor symptoms

 U.S. Food and Drug Administration today approved the Brio Neurostimulation System, an implantable deep brain stimulation device to help reduce the symptoms of Parkinson’s disease and essential tremor, a movement disorder that is one of the most common causes of tremors. The Brio Neurostimulation System can help some patients when medication alone may not provide...

Read More

Drug Shortages: Has the FDA Response Made an Impact?

Rationing of much needed medications for patients is a scary thought for me as a healthcare professional. I can understand when an orphan drug may go in short supply for a rare disease, but when commonly used medications like antibiotics and intravenous fluids become scarce, I wonder what the forces are that cause this to happen, and why can’t it be prevented? Worse yet,...

Read More

FDA Approves Addyi

Addyi (flibanserin) Tablets Company: Sprout Pharmaceuticals, Inc.Date of Approval: August 18, 2015Treatment for: Hypoactive Sexual Desire Disorder Addyi is the first and only FDA-approved treatment for hypoactive sexual desire disorder, the most common form of female sexual dysfunction.The U.S. FDA has approved Addyi (flibanserin), a once-daily, non-hormonal, multifunctional...

Read More

FDA Approves Repatha

FDA approved: Yes (First approved August 27th, 2015) Brand name: Repatha Generic name: evolocumab Company: Amgen Inc. Treatment for: High Cholesterol, Familial Heterozygous, High Cholesterol, Familial Homozygous,High Cholesterol Repatha (evolocumab) is a monoclonal antibody targeting PCSK9 (proprotein convertase subtilisin/kexin type 9) for the...

Read More

FDA Approves Aristada

Aristada Generic Name: aripiprazole lauroxilDate of Approval: October 5, 2015Company: Alkermes, Inc. Aristada is the first atypical antipsychotic with once-monthly and six-weekly dosing options. The U.S. Food and Drug Administration (FDA) has approved Aristada (aripiprazole lauroxil), an extended-release injectable atypical antipsychotic for the treatment of patients...

Read More